Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Breast Neoplasms 1

Interventions

Cisplatin 18 pembrolizumab 12 Paclitaxel 9 Carboplatin 9 Radiotherapy 5 Gemcitabine 4 Fluorodeoxyglucose F18 4 Colposcopy 4 Brachytherapy 4 fludarabine 3 durvalumab 3 Surveys and Questionnaires 3 Radiation 3 Flow Cytometry 3 Cyclophosphamide 3 Biopsy 3 Bevacizumab 3 toripalimab 2 fludarabine phosphate 2 atezolizumab 2 aldesleukin 2 adavosertib 2 Zoledronic Acid 2 Topotecan 2 Nivolumab 2 Neoadjuvant Therapy 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Uterine Cervical Neoplasms × CP protocol × Clear all

NCT04016142 2026-03-18

ACCRAPAN

Centre Oscar Lambret

Phase 2 Terminated

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡